TGM2 and cancer: In several types of cancer, drug-sensitivity can be restored using combined therapy with inhibitors of NF-ĸB, a known activator of TGM2 expression 18, and inhibition of TG2 enhances antitumor efficacy of pharmacological molecules 19.